Quoted from http://www.medpagetoday.com/Orthopedics/Orthopedics/45827
Medtronic's Infuse Moves From Operating Room to Courtroom
Published: May 18, 2014
By John Fauber, Reporter, Milwaukee Journal Sentinel/MedPage Today
Three years after back surgery, Grace Nestler-Bramm learned that a drug designed to repair her spine was causing new bone growth, growth that was wrapping around the spine and compressing nerves.
By then it was too late. The bony overgrowth associated with Infuse already had done irreparable damage.
She is now disabled by pain, and has difficulty walking -- often needing a cane or wheel chair when she leaves her home. Doctors have told her that additional surgery to fix the problem would be too dangerous.
In March, the Cedar Grove, Wis. resident became one of nearly 1,000 people who are suing Medtronic, the company that markets Infuse, a spinal fusion device that elutes bone morphogenetic protein-2 0r BMP-2.
That number of plaintiffs likely will grow.